147 related articles for article (PubMed ID: 6429025)
1. B-lymphoproliferative disorders: a proposed unified pathogenetic pathway.
Ezdinli EZ; Nanus DM
Hematol Oncol; 1983; 1(4):297-319. PubMed ID: 6429025
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte surface markers in lymphoproliferative disorders.
Aiuti F; Lacava V; Fiorilli M; Ciarla MV
Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
[No Abstract] [Full Text] [Related]
3. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
Ponzone A; Tarocco RP; Nicola P
Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
[No Abstract] [Full Text] [Related]
4. Detection of cytoplasmic immunologlobulin in well-differentiated lymphoproliferative diseases by the immunoperoxidase method.
Pangalis GA; Nathwani BN; Rappaport H
Cancer; 1980 Mar; 45(6):1334-9. PubMed ID: 6986977
[No Abstract] [Full Text] [Related]
5. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
Mantovani G; Petrini MT; Tognella S; Grifoni V
Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
[No Abstract] [Full Text] [Related]
6. Malignant lymphomas of B-cell type.
Stein H; Lennert K; Parwaresch MR
Lancet; 1972 Oct; 2(7782):855-7. PubMed ID: 4116558
[No Abstract] [Full Text] [Related]
7. [B lymphoproliferative syndrome with characteristics common to chronic lymphatic leukemia, Waldenström disease and plasmacytic leukemia].
Tosato F; Fossaluzza V; Sala P; Tonutti E
Minerva Med; 1984 Nov; 75(44):2691-4. PubMed ID: 6440066
[TBL] [Abstract][Full Text] [Related]
8. Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual.
Wang E; Kulbacki E; Stoecker M
Hum Pathol; 2012 Jul; 43(7):1135-41. PubMed ID: 22404949
[TBL] [Abstract][Full Text] [Related]
9. Discoid lupus erythematosus with macroglobulinemia. Correlations between autoimmunity and B cell malignancy with hyperimmunoglobulinemia.
Abdou NL; Abdou NI
Am J Med; 1974 Oct; 57(4):631-7. PubMed ID: 4215319
[No Abstract] [Full Text] [Related]
10. Surface IgD in immunoproliferative disorders.
Preud'homme JL; Brouet JC; Clauvel JP; Seligmann M
Scand J Immunol; 1974; 3(6):853-8. PubMed ID: 4218365
[No Abstract] [Full Text] [Related]
11. Immunoregulation and differentiation markers in monoclonal gammopathies.
Ricci C; Cascio G; Canavera R; Basso M; Baldassi R
Acta Haematol; 1987; 78 Suppl 1():50-5. PubMed ID: 3124450
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathy in lymphoma.
Alexanian R
Arch Intern Med; 1975 Jan; 135(1):62-6. PubMed ID: 1089397
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of immunologic reactivity of lymphocytes from patients with chronic lymphocytic leukemia in various clinical conditions.
Traczyk Z; Cieśluk S; Litwin J; Arczyńska E
Arch Immunol Ther Exp (Warsz); 1975; 23(5):589-96. PubMed ID: 766725
[No Abstract] [Full Text] [Related]
14. Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases.
Piessens WF; Schur PH; Moloney WC; Churchill WH
N Engl J Med; 1973 Jan; 288(4):176-80. PubMed ID: 4629847
[No Abstract] [Full Text] [Related]
15. B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.
Seligmann M; Preud'Homme JL; Brouet JC
Transplant Rev; 1973; 16():85-113. PubMed ID: 4204588
[No Abstract] [Full Text] [Related]
16. Cytological and functional criteria for the classification of malignant lymphomata.
Lennert K; Stein H; Kaiserling E
Br J Cancer Suppl; 1975 Mar; 2():29-43. PubMed ID: 52366
[TBL] [Abstract][Full Text] [Related]
17. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
18. [Chromosomal behavior in human neoplastic diseases].
Hossfeld DK
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(2):123-8. PubMed ID: 4264839
[No Abstract] [Full Text] [Related]
19. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
Berceanu S; Gociu M
Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
[No Abstract] [Full Text] [Related]
20. Surface immunoglobulins in chronic lymphatic leukaemia, macroglobulinaemia and myelomatosis.
Knapp W; Schuit HR; Bolhuis RL; Hijmans W
Clin Exp Immunol; 1974 Apr; 16(4):541-52. PubMed ID: 4219765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
